title: [Future vaccines].
abstract: Powerful genetic and immunological techniques allow the production of new vaccines. Recombinant proteins and synthetic peptides represent new categories of subunit vaccines, illustrated, respectively, by recombinant hepatitis B vaccines and a peptide-derived malaria vaccine. Virus and bacteria can be used as vectors of foreign genes encoding antigens of vaccinal interest, to build-up new forms of live vaccines. One may expect from these new strategies of vaccine production a better control of viral, bacterial and parasitic diseases and a dramatic change in vaccine recommendations for children and adults.
authors.affiliation: Laboratoire d'immunopathologie clinique et expérimentale, Centre hospitalier universitaire Charles Nicolle, Rouen.
authors.forename: F
authors.initials: F
authors.lastname: Tron
mesh_terms: D000328:Adult; D002648:Child; D006801:Humans; D014611:Vaccination / Q000639:trends*; D014612:Vaccines / Q000145:classification / Q000276:immunology
chemical_list: D014612:Vaccines
vernacular_title: Les vaccins du futur.